Dr. Park is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511
Summary
Education & Training
- Corewell Health East Beaumont (Royal Oak)Chief Residency, Radiation Oncology, 2010 - 2011
- Corewell Health East Beaumont (Royal Oak)Residency, Radiation Oncology, 2007 - 2011
- Corewell Health East Beaumont (Royal Oak)Internship, Transitional Year, 2006 - 2007
- Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2006
Certifications & Licensure
- MN State Medical License 2011 - 2026
- OK State Medical License 2020 - 2025
- WI State Medical License 2013 - 2025
- MI State Medical License 2006 - 2011
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Junior Appointment Alpha Omega Alpha (AOA), 2005
- Research Scholar Grant Recipient RSNA
- Merit Award ASCO Breast Cancer Symposium
- Join now to see all
Clinical Trials
- Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy Start of enrollment: 2013 Jan 02
- SBRT for Oligometastatic Castration-Refractory Prostate Cancer Start of enrollment: 2016 Mar 01
- Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma Start of enrollment: 2020 Dec 14
Publications & Presentations
PubMed
- Emergence of Circulating Tumor DNA as a Precision Biomarker in Lung Cancer Radiation Oncology and Beyond.Ayesha Hashmi, Lilli J Greiner, Pradeep S Chauhan, Jeffrey J Szymanski, Sean Park
Hematology/oncology Clinics of North America. 2025-04-01 - Dose Deintensified 3-Day Photon, Proton, or Brachytherapy: A Nonrandomized Controlled Partial Breast Irradiation Trial.Robert W Mutter, Michael A Golafshar, Matthew R Buras, Bryce P Comstock, Maddi Jacobson
International Journal of Radiation Oncology, Biology, Physics. 2025-02-01 - PSMA+ Extracellular Vesicles are a Biomarker for SABR in Oligorecurrent Prostate Cancer Analysis from the STOMP-like and ORIOLE trial cohorts.Jack Andrews, Yohan Kim, Edlira Horjeti, Ali Arafa, Heather Gunn
Clinical Cancer Research. 2025-01-16
Professional Memberships
- Member
- Member
- Member
- Member
- Member
Other Languages
- Korean
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: